SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TheraTech (THRT)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: geoffrey Wren who wrote (119)9/29/1998 2:56:00 AM
From: geoffrey Wren  Read Replies (1) of 125
 
Relevant news stories?

I have read three stories of technical innovations that may be important to THRT.

One, is that there will soon be a new "super aspirin," that has all the benefit of NSAID's, but side effects reduced by something like 99%. This makes the recent press release less exciting, as new ways of administering NSAID's to specific tissues may be less important. This new drug is close to final approval. The New Yorker had an article about the new drug roughly a month ago.

Two, there is a new way of administering VIAGRA, sort of like an underarm deodorant. This was on my local news tonight. I wonder if THRT has any involvement.

Three, there are drugs close to final approval that are effective against the flu, reducing it about 30% in severity and duration. Said to be administered by oral inhalation. The story was was in the SF Chronicle I believe, within the last few days. I wonder if THRT has any involvement in such drug administration.

Geoff Wren
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News